BXRX Stock Price, News & Analysis
Company Description
BXRX (OTC: BXRX) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.
BXRX stock has declined 98.7% over the past year.
This page provides a comprehensive overview of BXRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BXRX (BXRX) stock. Over the past 12 months, the stock has lost 98.7%.
Latest News
BXRX has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, fda approval, conferences, offering, earnings. View all BXRX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BXRX Company Profile & Sector Positioning
BXRX (BXRX) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.